Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Oncology

• Publication date

  2009-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1200/JCO.2007.15.4195PMID 19289631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

  2008cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma

  2008cited by this paper
• Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma.

  2008cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma

  2006cited by this paper
• Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

  2006cited by this paper
• Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

  2006cited by this paper
• Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve.

  2006cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.

  2006cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis

  2006cited by this paper
• Predicting which children are at risk for ependymoma relapse

  2006cited by this paper
• Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.

  2005cited by this paper
• Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children

  2005cited by this paper
• Radial glia cells are candidate stem cells of ependymoma.

  2005cited by this paper
• Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas

  2004cited by this paper
• Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia

  2004cited by this paper
• Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

  2003cited by this paper
• Ependymoma

  2003cited by this paper
• Prognostic value of ERBB family mRNA expression in breast carcinomas

  2003cited by this paper
• Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.

  2002cited by this paper
• Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.

  2002cited by this paper
• Current management of childhood ependymoma.

  2002cited by this paper
• Genetic abnormalities detected in ependymomas by comparative genomic hybridisation

  2002cited by this paper
• Immunohistochemical Markers for Prognosis of Ependymal Neoplasms

  2002cited by this paper
• Clinical impact and functional aspects of tenascin‐C expression during glioma progression

  2002cited by this paper
• Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH

  2002cited by this paper
• Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma

  2001cited by this paper
• Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.

  2001cited by this paper
• Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

  2001cited by this paper
• Karyotype studies in 18 ependymomas with literature review of 107 cases.

  1999cited by this paper
• Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma

  1999cited by this paper
• Evidence for functional and physical association between Caenorhabditis elegans SEL-10, a Cdc4p-related protein, and SEL-12 presenilin.

  1998cited by this paper
• Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

  1998cited by this paper

• Advances in molecular prognostication and treatments in ependymoma

  2025cites this paper
• Recurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.

  2022cites this paper
• The biology of ependymomas and emerging novel therapies

  2022cites this paper
• Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review)

  2022cites this paper
• Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.

  2021cites this paper
• Molecular Classification and Therapeutic Targets in Ependymoma

  2021cites this paper
• Targeting fibroblast growth factor receptors to combat aggressive ependymoma

  2021cites this paper
• Clinical experience and management outcome of WHO grade II pediatric intramedullary ependymomas: A descriptive study

  2021cites this paper
• Ependymoma relapse goes along with a relatively stable epigenome, but a severely altered tumor morphology

  2020cites this paper
• Pleiotropic Role of Tenascin-C in Central Nervous System Diseases: From Basic to Clinical Applications

  2020cites this paper
• Modeling the Interaction between the Microenvironment and Tumor Cells in Brain Tumors.

  2020cites this paper
• Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor

  2019cites this paper
• Molecular Characteristics of Pediatric Ependymomas: A Systematic Review

  2019influential citation
• Expression and Clinical Significance of Translation Regulatory Long Non-Coding RNA 1 (TRERNA1) in Ependymomas

  2019cites this paper
• Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression

  2019cites this paper
• Notch Inhibitors and the BET Inhibitor JQ-1 Decrease the Growth of Primary Tumor Cells Derived from a Novel Mouse Model of C11orf95-RELA Induced Brain Tumor

  2019cites this paper
• Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?

  2018cites this paper
• 15 Regulation of Glioma Stem Cells by the Notch Signaling Pathway : Mechanisms and Therapeutic Implications

  2018cites this paper
• Molecular Biology of Human Brain Tumors

  2017cites this paper
• Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification

  2017cites this paper
• Multi-nucleated glial cells and the implication for neural health

  2017cites this paper
• Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.

  2016cites this paper
• The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective

  2016cites this paper
• [Pediatric ependymomas: Current diagnosis and therapy].

  2016cites this paper
• Investigating therapies in ependymoma

  2016cites this paper
• Pediatric Ependymoma

  2016cites this paper
• Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches

  2016cites this paper
• Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases

  2016cites this paper
• The enigma of ependymal tumors: a journey in their genomic and transcriptomic landscapes

  2016cites this paper
• Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma

  2016cites this paper
• Principles of Molecular Biology in Posterior Fossa Tumors

  2015cites this paper
• Advances in Management of Pediatric Ependymomas

  2015cites this paper
• The potential for epigenetic analysis of paediatric CNS tumours to improve diagnosis, treatment and prognosis.

  2015cites this paper
• Translating preclinical hopes into clinical reality for children with ependymoma.

  2015cites this paper
• The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features.

  2015cites this paper
• C11orf95–RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma

  2015cites this paper
• Original A rticle Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases

  2015cites this paper
• Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.

  2015cites this paper
• Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases

  2015cites this paper
• Notch Pathway Blockade in Human Glioblastoma Stem Cells Defines Heterogeneity and Sensitivity to Neuronal Lineage Commitment

  2014cites this paper
• The Genetic and Epigenetic Basis of Posterior Fossa Ependymoma

  2014cites this paper
• Brain Tumor Genomics: Sequencing to Clinical Utility

  2014cites this paper
• C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma

  2014cites this paper
• Diagnosing relapse in children's brain tumors using metabolite profiles.

  2014cites this paper
• The fine structure of ependymomas.

  2014cites this paper
• The fine structure of ependymomas REVIEW

  2014cites this paper
• Genomic characterization of ependymomas reveals 6q loss as the most common aberration

  2014cites this paper
• Initial testing (stage 1) of the notch inhibitor PF‐03084014, by the pediatric preclinical testing program

  2014cites this paper
• Central nervous system tumors.

  2013cites this paper
• Current and evolving knowledge of prognostic factors for pediatric ependymomas.

  2013influential citation
• Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.

  2013influential citation
• The oncogenic role and the prognostic value of NOTCH3 gene in human malignant glioma

  2013cites this paper
• Ependymoma in children: molecular considerations and therapeutic insights

  2013influential citation
• Notch receptors in human choroid plexus tumors.

  2013cites this paper
• Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas

  2013cites this paper
• ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma

  2013cites this paper
• Histologic grade and extent of resection are associated with survival in pediatric spinal cord ependymomas

  2013cites this paper
• Pediatric Cancer, Volume 3

  2012cites this paper
• Pediatric Multiple Primary Cranio-Spinal Tumors Associated with Neurofibromatosis Type 2: Combined Therapeutical Strategies

  2012cites this paper
• Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.

  2012cites this paper
• Nestin Expression Identifies Ependymoma Patients with Poor Outcome

  2012cites this paper
• Progressively Metastasizing Ependymoma: Genomic Aberrations

  2012cites this paper
• Molecular approaches to ependymoma: the next step(s).

  2012cites this paper
• Characterization of transgenic mice expressing cancer‐associated variants of human NOTCH1

  2012cites this paper
• Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas

  2012cites this paper
• Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ‐secretase inhibitor targeting notch signaling

  2012cites this paper
• Pediatric ependymomas: will molecular biology change patient management?

  2011cites this paper
• Molecular genetics of ependymoma

  2011cites this paper
• Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

  2011cites this paper
• Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells

  2011cites this paper
• Polymorphic variants in tenascin-C (TNC) are associated with atherosclerosis and coronary artery disease

  2011cites this paper
• Regulation of Glioma Stem Cells by the Notch Signaling Pathway: Mechanisms and Therapeutic Implications

  2011cites this paper
• Function of Tenascins in the Tumor Stroma

  2011cites this paper
• Challenging issues in pediatric oncology

  2011cites this paper
• A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat

  2011cites this paper
• Hairy-related transcription factor 2 is not potentially related to congenital heart disease in Chinese patients.

  2011cites this paper
• Childhood Brain Tumors

  2011cites this paper
• The neurobiology of gliomas: from cell biology to the development of therapeutic approaches

  2011cites this paper
• Using mouse models to investigate the genetics of T-cell acute lymphocytic leukemia

  2011cites this paper
• Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis

  2010cites this paper
• Notch signaling in glioblastoma: a developmental drug target?

  2010cites this paper
• The Genetics of Pediatric Brain Tumors

  2010cites this paper
• Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas.

  2010cites this paper
• Molecular staging of intracranial ependymoma in children and adults.

  2010cites this paper
• Cross-species genomics matches driver mutations and cell compartments to model ependymoma

  2010cites this paper
• Cancer and the Nervous System

  2008cites this paper